Autoantibodies to a major carboxyl-terminal epitope on ribosomal p proteins are clonally restricted and display a common heavy- and light-chain pairing signature: a forbidden clone in human lupus

Pathology ◽  
2013 ◽  
Vol 45 ◽  
pp. S97
Author(s):  
M. Al Kindi ◽  
G. Arentz ◽  
T.K. Chattaway ◽  
R. Lindop ◽  
M.W. Jackson ◽  
...  
2001 ◽  
Vol 15 (14) ◽  
pp. 2602-2612 ◽  
Author(s):  
Pablo López Bergami ◽  
Jorge Scaglione ◽  
Mariano Jorge Levin

1979 ◽  
Author(s):  
H. Kato ◽  
T. Sugo ◽  
N. Ikari ◽  
N. Hashimoto ◽  
S. Iwanaga ◽  
...  

Bovine HMW kininogen (HMW-K) has a mol. wt. of 76,000 and the carboxyl-terminal 243 residues consisting of kinin, fragment 1.2 and light chain regions have been sequenced. The purpose of this study is to elucidate the functional regions of the kininogen which are required for the kaolin-mediated activation of Factor XII (XII) in the presence of prekallikrein (Prek). The results were as follows: (1) Kaolin-mediated activation of XII was accelerated 180 fold by adding optimum amounts of HMW-K. (2) The accelerating effect of HMW-K markedly increased by the brief treatment with kallikrein, indicating that a nicked HMW-K, named “Active Kininogen”, is most effective. (3) The same accelerating effect as HMW-K was observed with fragment 1.2-light chain. (4) Prek formed a complex with HMW-K and kinin-fragment 1.2-free protein. Kallikrein also formed a complex with kinin-fragment 1.2-free protein. (5) The adsorption of HMW-K on kaolin was inhibited by fragment 1.2. These results indicate that HMW-K accelerates kaolin-mediated activation or XII by forming a complex with Prek through the light chain region and by interacting with kaolin through the fragment 1.2 region. It was also suggested that plasma kallikrein plays an important role not only In the positive feedback activation of XII but also In the transformation of HMW-K to an “Active Kininogen”.


1995 ◽  
Vol 179 (2) ◽  
pp. 193-202 ◽  
Author(s):  
L. Caponi ◽  
S. Pegoraro ◽  
V. Di Bartolo ◽  
P. Rovero ◽  
R. Revoltella ◽  
...  

Biochemistry ◽  
1997 ◽  
Vol 36 (47) ◽  
pp. 14439-14446 ◽  
Author(s):  
Reina Zambrano ◽  
Elisa Briones ◽  
Miguel Remacha ◽  
Juan P. G. Ballesta
Keyword(s):  

2000 ◽  
Vol 95 (2) ◽  
pp. 99-103 ◽  
Author(s):  
Kim Rayno ◽  
Morris Reichlin
Keyword(s):  

1999 ◽  
Vol 262 (2) ◽  
pp. 606-611 ◽  
Author(s):  
Patricia Bargis-Surgey ◽  
Jean-Pierre Lavergne ◽  
Philippe Gonzalo ◽  
Cecile Vard ◽  
Odile Filhol-Cochet ◽  
...  

1991 ◽  
Vol 174 (3) ◽  
pp. 507-514 ◽  
Author(s):  
J L Chu ◽  
N Brot ◽  
H Weissbach ◽  
K Elkon

The ribosomal P proteins are necessary for GTPase activity during protein synthesis. In addition to antibodies to the P proteins, sera from lupus patients contain anti-rRNA activity. To determine whether lupus antiribosomal sera recognize the region of 28S rRNA recently proposed to form part of the ribosomal GTPase center, an rRNA fragment corresponding to nucleotides (nt) 1922-2020 was transcribed in vitro and tested for antigenicity. 18 of 24 (75%) lupus sera containing anti-P antibodies, but only 2 of 24 (8%) lupus sera without anti-P, immunoprecipitated this rRNA fragment (p less than 0.001). The binding was specific, since no significant differences were observed between anti-P positive and negative lupus sera in binding to the RNA fragment transcribed in the antisense orientation or to a control region of rRNA. The majority of sera tested protected a rRNA fragment of approximately 68 nucleotides. To evaluate the fine specificity of the anti-28S antibodies, deletions and site-directed mutations were made in the RNA fragment. The anti-28S antisera required nt 1944-1955 for recognition and were remarkably sensitive to destabilizing as well as nondestabilizing mutations in the stems of the RNA fragments. Detection of antiprotein and anti-RNA antibodies directed against a functionally related domain in the ribosome, together with the remarkable specificity of anti-28S antibodies, strongly suggests a direct role for this region of the ribosome in initiating and/or maintaining antiribosomal autoantibody production.


2011 ◽  
Vol 10 (3) ◽  
pp. 126-130 ◽  
Author(s):  
Patrícia Andrade de Macedo ◽  
Eduardo Ferreira Borba ◽  
Vilma dos Santos Trindade Viana ◽  
Elaine Pires Leon ◽  
Leonardo de Abreu Testagrossa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document